Creative Medical Technology Holdings Inc. stocks have been trading up by 58.49 percent amid heightened optimism over its regenerative therapies.
Click Here for a Millionaire's POV on Trading CELZ
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- CELZ has faded from late-July highs near $0.90 into the mid-$0.60s, signaling a clear short-term downtrend on the daily chart.
- Intraday CELZ action shows violent swings from $0.88 to $1.37, offering range but demanding strict risk control.
- Creative Medical Technology Holdings Inc. reports just $6,000 in quarterly revenue, while burning over $1.3M in operating cash.
- CELZ holds about $5.7M in cash and minimal liabilities, giving the company runway but not solving its heavy losses.
- Traders are watching whether CELZ can base above $0.65 or break down toward prior support levels.
Live Update At 08:34:40 EDT: On Thursday, August 06, 2026 Creative Medical Technology Holdings Inc. stock [NASDAQ: CELZ] is trending up by 58.49%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
CELZ is a classic high-risk, story-driven micro-cap. The latest report for Creative Medical Technology Holdings Inc. shows revenue of only $6,000 for the quarter, but a net loss of roughly $1.41M. That means the core business is not funding itself; CELZ is living off its balance sheet and capital raises.
The good news for traders is the balance sheet. CELZ carries total assets of about $6.44M and current assets near $6.06M, with current liabilities of only about $0.31M. That produces a huge current ratio near 19.7, so short-term bills are not the problem. Cash and restricted cash are a hefty $5.72M, giving Creative Medical Technology Holdings Inc. some breathing room.
More Breaking News
- RAM ETF Whipsaws As Traders Target DRAM Momentum
- ClearOne CLRO Slides As Cortigent Merger Triggers Legal Scrutiny
- Celestica CLS Stock Wobbles On $3B Share Offerings
- MTRN Stock Pops As Dividend And Earnings Catalysts Align
Profitability metrics are ugly. Return on assets and return on equity are deeply negative, and free cash flow for CELZ sits around -$1.32M for the quarter. With revenue shrinking sharply over the past three and five years, this is not a steady compounder. For traders, that mix—weak fundamentals plus strong cash runway—often fuels volatile, news-sensitive price action rather than slow, predictable trends.
Why Traders Are Watching CELZ Price Action
Traders do not crowd into CELZ for the fundamentals; they show up for the volatility. On the multi-day chart, Creative Medical Technology Holdings Inc. has rolled over hard. CELZ closed around $0.90 on 2026/07/13 and then dropped step by step, printing a recent close near $0.67 on 2026/08/05. That is roughly a 25% slide in a few weeks, clear enough for even new traders to spot the downtrend.
But CELZ still shows life on the intraday tape. In the 5-minute data, the stock ripped from about $0.88 at 06:55 up to a peak near $1.37 by 08:00, before fading back toward $1.06 by 08:30. For active traders, that is a massive intraday range—more than 50% swing from low to high in less than two hours. Creative Medical Technology Holdings Inc. trades like a scalper’s playground, not a quiet income name.
Technically, CELZ is trying to hold the mid-$0.60s after failing to defend the $0.80–$0.85 area. That prior zone now acts as overhead resistance. Short-term traders may eye bounces toward $0.75–$0.80 for potential exhaustion moves, while breakdown traders watch for a crack under $0.65 to open the door to deeper lows. In a thin name like CELZ, liquidity can vanish fast, so both long and short setups demand tight risk rules and clear levels.
Conclusion
Creative Medical Technology Holdings Inc. sits in that familiar micro-cap pocket: small revenue, big losses, plenty of cash for now, and a chart that moves like a rollercoaster. CELZ has sold off sharply from late-July highs, but intraday volatility remains extreme, with 5-minute candles showing relentless spikes and flushes. That combination keeps CELZ squarely on the radar for day traders focused on momentum and liquidity pockets.
The core numbers tell the real story. CELZ is not generating meaningful sales yet, and free cash flow is deeply negative. The strong current ratio and cash balance buy Creative Medical Technology Holdings Inc. time, but they do not guarantee future success. For traders, the key is to respect that gap between balance-sheet strength and income-statement weakness, and to treat every CELZ move as a potential trading opportunity, not a long-term promise. As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.” That mindset is critical when dealing with a name like CELZ, where emotional reactions to sharp spikes or sudden flushes can quickly lead to undisciplined decisions.
Tim Sykes hammers this lesson all the time: “I’m not in love with any stock, I’m in love with the process—plan the trade, trade the plan, and cut losses quickly when you’re wrong.” CELZ fits that mindset perfectly. It rewards discipline and punishes hope. Study the chart, define your levels, size small, and remember this is educational and research content, not a signal to buy or sell.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.